The most frequent (≥20%) all-grade treatment-related adverse events included CRS (60.6%), pyrexia (39.4%), increased alanine aminotransferase (30.3%), anemia (24.2%) and increased aspartate aminotransferase (24.2%). This evidence concerns the gene GPT and congenital rubella syndrome.